» Articles » PMID: 17055557

Involvement of Src Kinases and PLCgamma2 in Clot Retraction

Overview
Journal Thromb Res
Date 2006 Oct 24
PMID 17055557
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The integrin alpha(IIb)beta(3) plays a critical role in mediating clot retraction by platelets which is important in vivo in consolidating thrombus formation. Actin-myosin interaction is essential for clot retraction. In the present study, we demonstrate that the structurally distinct Src kinase inhibitors, PP2 and PD173952, significantly reduced the rate of clot retraction, but did not prevent it reaching completion. This effect was accompanied by abolition of alpha(IIb)beta(3)-dependent protein tyrosine phosphorylation, including PLCgamma2. A role for PLCgamma2 in mediating clot retraction was demonstrated using PLCgamma2-deficient murine platelets. Furthermore, platelet adhesion to fibrinogen leads to MLC phosphorylation through a pathway that is inhibited by PP2 and by the PLC inhibitor, U73122. These results demonstrate a partial role for Src kinase-dependent activation of PLCgamma2 and MLC phosphorylation in mediating clot retraction downstream of integrin alpha(IIb)beta(3).

Citing Articles

Filamin A regulates platelet shape change and contractile force generation via phosphorylation of the myosin light chain.

Hong F, Mollica M, Golla K, De Silva E, Sniadecki N, Lopez J Biochem J. 2024; 481(20):1395-1410.

PMID: 39189664 PMC: 11555712. DOI: 10.1042/BCJ20240114.


Single-pericyte nanomechanics measured by contraction cytometry.

Islam M, Gaska I, Oshinowo O, Otumala A, Shekhar S, Yong N APL Bioeng. 2024; 8(3):036109.

PMID: 39131206 PMC: 11316606. DOI: 10.1063/5.0213761.


Comparative antiplatelet and antithrombotic effects of red ginseng and fermented red ginseng extracts.

Irfan M, Lee Y, Lee K, Kim S, Rhee M J Ginseng Res. 2022; 46(3):387-395.

PMID: 35600768 PMC: 9120646. DOI: 10.1016/j.jgr.2021.05.010.


1,8-Cineole Affects Agonists-Induced Platelet Activation, Thrombus Formation and Haemostasis.

Alatawi K, Ravishankar D, Patra P, Bye A, Stainer A, Patel K Cells. 2021; 10(10).

PMID: 34685597 PMC: 8533741. DOI: 10.3390/cells10102616.


Clot Retraction: Cellular Mechanisms and Inhibitors, Measuring Methods, and Clinical Implications.

Jansen E, Hartmann M Biomedicines. 2021; 9(8).

PMID: 34440268 PMC: 8394358. DOI: 10.3390/biomedicines9081064.


References
1.
Woodside D, Obergfell A, Talapatra A, Calderwood D, Shattil S, Ginsberg M . The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains. J Biol Chem. 2002; 277(42):39401-8. DOI: 10.1074/jbc.M207657200. View

2.
Suzuki-Inoue K, Inoue O, Frampton J, Watson S . Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase. Blood. 2003; 102(4):1367-73. DOI: 10.1182/blood-2003-01-0029. View

3.
Straight A, Cheung A, Limouze J, Chen I, Westwood N, Sellers J . Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science. 2003; 299(5613):1743-7. DOI: 10.1126/science.1081412. View

4.
Leng L, Kashiwagi H, Ren X, Shattil S . RhoA and the function of platelet integrin alphaIIbbeta3. Blood. 1998; 91(11):4206-15. View

5.
Jenkins A, Silver D, Sellers J, Ginsberg M, Law D, Phillips D . Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J Biol Chem. 1998; 273(22):13878-85. DOI: 10.1074/jbc.273.22.13878. View